Denmark· DK-28107548225
Rylaxtol
A minoxidil product containing minoxidil, registered in Denmark by 2care4 Generics ApS. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Minoxidil is registered in 9 of 19 countries.
Countries holding a registration under ATC C02DC01 (minoxidil), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 3 of them publish a price we can compare per daily dose
Minoxidil · ATC C02DC01
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of minoxidil costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Minoxidil · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- FR France$0.70
- US United States$0.55 (acquisition cost)
- ES Spain$0.48
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Minoxidil
- Manufacturer
- 2care4 Generics ApS
- Country
- Denmark (DK)
- ATC code
- C02DC01
- ATC class
- Minoxidil
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107548225
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
330 interactions on record for minoxidil.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Minoxidil · interactions on record
330 records
- 2 severe
- 187 moderate
- 2 minor
- 139 info
Most severe, free to view
- GuanethidineC02CC02severe
- TizanidineM03BX02severe
- DimenhydrinatA04AB02moderate
- ThiethylperazinA04AB03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C02DC01
Minoxidil, as other registers publish it.
- United States5%MinoxidilHairgrowthSprayGuangzhou Yixin Cross-border E-commerce Co., Ltd.
- United States5%MINOXIDILHAIRGROWTHSPRAYGuangzhou Yixin Cross-border E-commerce Co., Ltd.
- NorwayLonitenPharmacia & Upjohn Company LLC
- NorwayLonitenPharmacia & Upjohn Company LLC
- CanadaLONITEN 10MGPFIZER CANADA ULC
- United KingdomLoniten 10mg tabletsMawdsley-Brooks & Company Ltd
- United KingdomLoniten 10mg tabletsWaymade Healthcare Plc
- United KingdomLoniten 10mg tabletsPfizer Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/def27475-33fc-4078-9878-e7f2400a7942 GET /v1/drugs/def27475-33fc-4078-9878-e7f2400a7942?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter",
"source": "dkma",
"strength": "2,5 mg",
"auth_role": "CMS",
"dk_drugid": "28107548225",
"substance": "Minoxidil",
"auth_procedure": "MRP",
"in_medicinpriser": false,
"registration_date_serial": "46212"
}See everything about minoxidil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.